Waylis Therapeutics LLC
Waylis Therapeutics LLC is listed as the manufacturer on 2 FDA drug label records covering 2 distinct active ingredients predominantly human prescription drug products.
About Waylis Therapeutics LLC
Waylis Therapeutics LLC is named as the labeler on 2 FDA drug label records. Its catalogue spans 2 distinct active ingredients, led by CARVEDILOL, FLUTAMIDE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: heart failure, eulexin capsules, left ventricular, myocardial infarction, coreg indicated, clinical studies, stage metastatic, radiation therapy. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| CARVEDILOL | 1 |
| FLUTAMIDE | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | ORAL | 2 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Waylis Therapeutics LLC
Frequently asked questions
How many FDA drug products does Waylis Therapeutics LLC make?
2 FDA drug label records name Waylis Therapeutics LLC as the manufacturer, covering 2 distinct active ingredients.
What active ingredients does Waylis Therapeutics LLC produce?
The most frequent active ingredients in this portfolio are CARVEDILOL, FLUTAMIDE.
Are Waylis Therapeutics LLC products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.